Autologous Tumor Infiltrating Lymphocytes MDA-TIL
2017-0671
Phase 2 mab terminated
Quick answer
Autologous Tumor Infiltrating Lymphocytes MDA-TIL for Malignant Solid Neoplasm is a Phase 2 program (mab) at Iovance Biotherapeutics B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Iovance Biotherapeutics B.V.
- Indication
- Malignant Solid Neoplasm
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated